Results 101 to 110 of about 14,860 (180)

Smoking cessation and tobacco prevention in Indigenous populations [PDF]

open access: yes
This article systematically reviews 91 smoking cessation and tobacco prevention studies tailored for Indigenous populations around the world, with a particular focus on Aboriginal and Torres Strait Islander populations in Australia. We identified several
Adrian Esterman   +9 more
core   +1 more source

Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline in a 2-lever, rat self-administration paradigm [PDF]

open access: yes, 2013
Nicotine (NIC) has two reinforcement-related effects that may contribute to dependence: 1) NIC acts as a primary reinforcer, and 2) NIC, non-associatively, enhances reinforcement from concur- rently available nonpharmacological stimuli. Varenicline (VAR),
Levin, Melissa
core  

Varenicline: A review of the literature and place in therapy

open access: yesPharmacy Practice, 2007
Evidence regarding the health consequences of smoking is undeniable, yet 21% of the American population continues to smoke. In addition to behavioral modifications, first-line treatment options include nicotine replacement therapies and bupropion SR ...
Whitley HP, Moorman KL.
doaj  

Vareniclina. Un paso más en la lucha contra el tabaquismo [PDF]

open access: yes, 2007
Recientemente la Food and Drugs Administration ha aprobado Vareniclina, fármaco para la deshabituación tabáquica que presenta un novedoso mecanismo de acción, agonismo parcial de receptores nicotínicos de acetilcolina a4ß2.Hemos revisado la farmacología,
Donat, Lucas   +5 more
core  

Use of low-dose varenicline in hospitalized smokers: A case series low-dose varenicline in hospitalized smokers

open access: yesSAGE Open Medical Case Reports
Nicotine replacement therapy is the primary medication used to treat tobacco dependence in hospitalized patients. Recent evidence shows that varenicline is more effective than nicotine replacement, but varenicline side effects limit its use in the ...
Rachael L. Joyner   +3 more
doaj   +1 more source

Nicotinic acetylcholine receptor-mediated effects of varenicline on LPS-elevated prostaglandin and cyclooxygenase levels in RAW 264.7 macrophages

open access: yesFrontiers in Molecular Biosciences
Introduction: The purpose of this study is to delineate anti-inflammatory and antioxidant potential of varenicline, a cigarette smoking cessation aid, on decreasing lipopolysaccharide (LPS)-elevated proinflammatory cytokines in RAW 264.7 murine ...
Elif Baris   +2 more
doaj   +1 more source

Smoking cessation: an economic analysis and review of varenicline

open access: yesClinicoEconomics and Outcomes Research, 2009
Michele A FaulknerCreighton University School of Pharmacy and Health Professions, Omaha, NE, USAAbstract: Despite efforts to decrease tobacco use, smoking continues to be a leading cause of preventable morbidity and premature death.
Michele A Faulkner
doaj  

Leading Causes of Death in Vietnam [PDF]

open access: yes, 2017
Vietnam is currently facing a public health crisis. Rates of chronic and preventable diseases are climbing, in addition to mortality rates from these diseases.
Roth, Lindsey
core   +1 more source

Binding Interactions with the Complementary Subunit of Nicotinic Receptors [PDF]

open access: yes, 2013
The agonist-binding site of nicotinic acetylcholine receptors (nAChRs) spans an interface between two subunits of the pentameric receptor. The principal component of this binding site is contributed by an α subunit, and it binds the cationic moiety of ...
Blum, Angela P.   +4 more
core  

Smoking cessation in Asians: focus on varenicline

open access: yesPatient Preference and Adherence, 2015
Dan Xiao,* Shuilian Chu,* Chen Wang Clinical Cessation and Tobacco Medicine Research Centre, China-Japan Friendship Hospital, Beijing, People’s Republic of China *These authors are the co-first authors Abstract: Smoking is a modifiable risk ...
Xiao D, Chu S, Wang C
doaj  

Home - About - Disclaimer - Privacy